#United States #New York City #Investor Day #Quest Diagnostics #Jim Davis

Quest Diagnostics Invites Investors for an Insightful Day

On March 19, 2025, Quest Diagnostics, a prominent player in the diagnostic information services sector, will hold its much-anticipated Investor Day at the New York Stock Exchange. This significant event will gather institutional investors and financial analysts to share crucial updates concerning the company's strategy and outlook.

Event Highlights

The Investor Day promises to be a key opportunity for Quest Diagnostics to communicate its vision for the future amidst an evolving healthcare landscape. Key executives scheduled to present include Jim Davis, the Chairman, CEO, and President, alongside Sam Samad, the Executive Vice President and Chief Financial Officer, among others.

During the event, attendees can look forward to:

• - An in-depth analysis of the current state of the U.S. laboratory market.
• - Insights into Quest's business strategy and priorities for capital deployment.
• - A long-term outlook addressing the company’s growth and transformational initiatives.

Given the complexity and dynamics of the healthcare industry, this Investor Day serves as a crucial platform for Quest Diagnostics to engage with its stakeholders. Participants will be provided with updated perspectives that can aid in understanding the company's role and performance in the diagnostic sector.

Registration and Webcast

To participate, registration in advance is required. Interested individuals can sign up through the Quest Diagnostics 2025 Investor Day Registration page. Furthermore, for those unable to attend, a live webcast of the presentations will be available via the Quest Diagnostics Investor Relations website. Post-event, an archived version of the webcast will also be accessible for review.

Quest Diagnostics: A Brief Overview

Founded with the mission to enhance healthcare and diagnostic insights, Quest Diagnostics has built one of the world's largest databases of clinical lab results. The company annually serves approximately one-third of adult Americans and is a trusted partner to half of the nation's physicians and hospitals.

Employing over 55,000 individuals, Quest Diagnostics embodies a commitment to transforming healthcare through actionable insights derived from its laboratory testing services. The organization's work not only identifies diseases but also inspires healthier lifestyles and improves overall health management.

As the healthcare landscape continues to shift, the role of diagnostic insights becomes increasingly vital, enabling patients, physicians, and healthcare organizations to make informed decisions. This upcoming Investor Day will potentially highlight the steps Quest Diagnostics plans to take to navigate these changes and leverage its resources effectively.

For more details about the Investor Day and ongoing updates, check the official Quest Diagnostics website.

This event marks a pivotal moment for Quest Diagnostics, allowing it to strengthen its connections with investors and stakeholders while elucidating its strategic focus for the future.